Opsona Therapeutics

Opsona Therapeutics
Opsona Therapeutics

Opsona Therapeutics is a drug development company specialising in the human immune system and new drugs and vaccines to prevent and treat autoimmune/inflammatory conditions, cancers and infectious diseases.[1][2][3]

Based in Ireland, Opsona is a spin-out from Trinity College Dublin (TCD)[4]. Ireland is ranked highly in the world in immunology research, and TCD has been at the forefront of the field [5].

Opsona's research is primarily focused on the role of Toll-like receptors (TLRs) and TLR signalling in human innate immunity. The company was founded in 2004 by three immunologists:

Opsona's main investors are international and life-science focused:

References


Wikimedia Foundation. 2010.

Игры ⚽ Нужна курсовая?

Look at other dictionaries:

  • Dermot P. Kelleher — Dermot P Kelleher is Head of the School of Medicine at the University of Dublin and one of the three founders of Opsona Therapeutics in 2004. Opsona s research is primarily focused on the role of Toll like receptors (TLRs) and TLR signalling in… …   Wikipedia

  • Trinity College, Dublin — The College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin Coláiste na Tríonóide, Baile Átha Cliath Coláiste Thríonóid Naofa Neamhroinnte na Banríona Eilís gar do Bhaile Átha Cliath Latin …   Wikipedia

  • Liste von Multiple-Sklerose-Wirkstoffen in der Erprobung — Für die immunmodulierende Langzeittherapie der Multiplen Sklerose sind derzeit acht Medikamente im deutschen Sprachraum zugelassen: drei Beta Interferone, Glatirameracetat, Mitoxantron, Azathioprin, Natalizumab und Fingolimod. Darüber hinaus gibt …   Deutsch Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”